Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Winning Catering Group, Inc.LiquidValue Development Inc. Reports Significant Revenue Decline and Net Loss in Q1 2025
FLYEXCLUSIVE INC.flyExclusive Reports 10.2% Revenue Growth and Narrowed Net Loss in Q1 2025
Verastem, Inc.Verastem Reports $52.1 Million Net Loss in Q1 2025, FDA Approves AVMAPKI FAKZYNJA
PARKERVISION INCParkerVision Reports $3.8 Million Net Loss in Q1 2025, No Revenue Generated
OptimizeRx CorpOptimizeRx Reports 11% Revenue Growth to $21.9 Million in Q1 2025
Quoin Pharmaceuticals, Ltd.Quoin Pharmaceuticals Reports $3.8 Million Net Loss in Q1 2025, Increases R&D Spending
FATE THERAPEUTICS INCFate Therapeutics Reports Q1 2025 Financial Results with Decreased Revenue and Improved Loss Per Share
INTERLINK ELECTRONICS INCInterlink Electronics Reports 14.7% Revenue Decline in Q1 2025
HeartBeam, Inc.HeartBeam Reports $5.5 Million Net Loss in Q1 2025, Highlights Growth in Assets and Product Developments
IZEA Worldwide, Inc.IZEA Worldwide Reports $7.97 Million Revenue in Q1 2025, 15% Increase Year-Over-Year
Savara IncSavara Inc. Reports $26.6 Million Net Loss in Q1 2025, Submits BLA for MOLBREEVI
Pluri Inc.Pluri Inc. Reports Revenue Growth to $938,000 Amid Ongoing Net Loss
Sky Harbour Group CorpSky Harbour Group Reports 133% Revenue Growth to $5.6 Million Despite Net Loss
Smart Sand, Inc.Smart Sand Reports 21% Revenue Decline and $24.2 Million Net Loss in Q1 2025
Texas Community Bancshares, Inc.Texas Community Bancshares Reports $643,000 Net Income in Q1 2025, Significant Turnaround from Prior Year
Bluejay Diagnostics, Inc.Bluejay Diagnostics Reports $1.86 Million Net Loss in Q1 2025, Seeks $30 Million in Funding
LQR House Inc.LQR House Inc. Reports Q1 2025 Financial Results with Revenue Decline and Increased Service Revenue
Astria Therapeutics, Inc.Astria Therapeutics Reports $33.7 Million Net Loss in Q1 2025, Increases R&D Spending
INTELLINETICS, INC.Intellinetics Reports $4.25 Million Revenue in Q1 2025, Faces Loss from Operations
INTENSITY THERAPEUTICS, INC.Intensity Therapeutics Reports $3.3 Million Net Loss in Q1 2025, Highlights Funding Challenges
INOVIO PHARMACEUTICALS, INC.Inovio Pharmaceuticals Reports $19.7 Million Net Loss and First Revenue in Q1 2025
MACROGENICS INCMacroGenics Reports 45% Revenue Growth to $13.2 Million in Q1 2025
SELLAS Life Sciences Group, Inc.SELLAS Life Sciences Reports Improved Q1 2025 Financial Results with Reduced Net Loss
Fractyl Health, Inc.Fractyl Health Reports No Revenue and Increased Losses in Latest 10-Q Filing
Flowco Holdings Inc.Flowco Holdings Reports 188% Revenue Growth to $192.4 Million in Q1 2025